Literature DB >> 33652762

Two Italian Patients with ELOVL4-Related Neuro-Ichthyosis:  Expanding the Genotypic and Phenotypic Spectrum and Ultrastructural Characterization.

Andrea Diociaiuti1,2, Diego Martinelli3, Francesco Nicita4, Claudia Cesario5, Elisa Pisaneschi5, Marina Macchiaiolo6, Sabrina Rossi7, Angelo Giuseppe Condorelli2, Giovanna Zambruno2, May El Hachem1,2.   

Abstract

Elongation of Very Long Chain Fatty Acid-4 (ELOVL4) is a fatty acid elongase responsible for very long-chain fatty acid biosynthesis in the brain, retina, and skin. Heterozygous mutations in ELOVL4 gene cause Stargardt-like macular dystrophy and spinocerebellar ataxia type-34, while different homozygous mutations have been associated with ichthyosis, spastic quadriplegia, and mental retardation syndrome in three kindred. We report the first two Italian children affected with neuro-ichthyosis due to the previously undescribed ELOVL4 homozygous frameshift variant c.435dupT (p.Ile146TyrfsTer29), and compound heterozygous variants c.208C>T (p.Arg70Ter) and c.487T>C (p.Cys163Arg), respectively. Both patients were born with collodion membrane followed by development of diffuse mild hyperkeratosis and scaling, localized erythema, and palmoplantar keratoderma. One infant displayed mild facial dysmorphism. They suffered from failure to thrive, and severe gastro-esophageal reflux with pulmonary aspiration. The patients presented axial hypotonia, hypertonia of limbs, and absent head control with poor eye contact from infancy. Visual evoked potentials showed markedly increased latency and poor morphological definition, indicative of alteration of the retro-retinal visual pathways in both patients. Ultrastructural skin examination revealed abnormalities of lamellar bodies with altered release in the epidermal granular and horny layer intracellular spaces. Our findings contribute to expanding the phenotypic and genotypic features of ELOVL4-related neuro-ichthyosis.

Entities:  

Keywords:  ELOVL4; collodion baby; developmental delay; dysmorphism; electron microscopy; epilepsy; ichthyosis; visual evoked potentials

Mesh:

Substances:

Year:  2021        PMID: 33652762      PMCID: PMC7996761          DOI: 10.3390/genes12030343

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  16 in total

1.  Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.

Authors:  Vidyullatha Vasireddy; Yoshikazu Uchida; Norman Salem; Soo Yeon Kim; Md Nawajesh Ali Mandal; Geereddy Bhanuprakash Reddy; Ravi Bodepudi; Nathan L Alderson; Johnie C Brown; Hiroko Hama; Andrzej Dlugosz; Peter M Elias; Walter M Holleran; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2007-01-05       Impact factor: 6.150

2.  Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.

Authors:  Maxime Cadieux-Dion; Maude Turcotte-Gauthier; Anne Noreau; Caroline Martin; Caroline Meloche; Micheline Gravel; Christian Allen Drouin; Guy A Rouleau; Dang Khoa Nguyen; Patrick Cossette
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

3.  Novel PNPLA1 mutations in two Italian siblings with autosomal recessive congenital ichthyosis.

Authors:  A Diociaiuti; E Pisaneschi; G Zambruno; A Angioni; A Novelli; R Boldrini; M El Hachem
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-10-27       Impact factor: 6.166

4.  A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.

Authors:  K Zhang; M Kniazeva; M Han; W Li; Z Yu; Z Yang; Y Li; M L Metzker; R Allikmets; D J Zack; L E Kakuk; P S Lagali; P W Wong; I M MacDonald; P A Sieving; D J Figueroa; C P Austin; R J Gould; R Ayyagari; K Petrukhin
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

5.  A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.

Authors:  Kokoro Ozaki; Hiroshi Doi; Jun Mitsui; Nozomu Sato; Yoichiro Iikuni; Takamasa Majima; Kiyomi Yamane; Takashi Irioka; Hiroyuki Ishiura; Koichiro Doi; Shinichi Morishita; Miwa Higashi; Teruhiko Sekiguchi; Kazuo Koyama; Naohisa Ueda; Yoshiharu Miura; Satoko Miyatake; Naomichi Matsumoto; Takanori Yokota; Fumiaki Tanaka; Shoji Tsuji; Hidehiro Mizusawa; Kinya Ishikawa
Journal:  JAMA Neurol       Date:  2015-07       Impact factor: 18.302

6.  De novo mutation in ELOVL1 causes ichthyosis, acanthosis nigricans, hypomyelination, spastic paraplegia, high frequency deafness and optic atrophy.

Authors:  Noomi Mueller; Takayuki Sassa; Susanne Morales-Gonzalez; Joanna Schneider; Daniel J Salchow; Dominik Seelow; Ellen Knierim; Werner Stenzel; Akio Kihara; Markus Schuelke
Journal:  J Med Genet       Date:  2018-11-28       Impact factor: 6.318

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

Review 8.  Genetics of Inherited Ichthyoses and Related Diseases.

Authors:  Judith Fischer; Emmanuelle Bourrat
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

9.  A novel recessive mutation in the gene ELOVL4 causes a neuro-ichthyotic disorder with variable expressivity.

Authors:  Hina Mir; Syed Irfan Raza; Muhammad Touseef; Mazhar Mustafa Memon; Muhammad Nasim Khan; Sulman Jaffar; Wasim Ahmad
Journal:  BMC Med Genet       Date:  2014-02-26       Impact factor: 2.103

10.  ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier.

Authors:  Benedikt Kien; Susanne Grond; Guenter Haemmerle; Achim Lass; Thomas O Eichmann; Franz P W Radner
Journal:  J Lipid Res       Date:  2018-10-25       Impact factor: 6.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.